 | • レポートコード：D0-MOR-AP0860 • 出版社/出版日：Mordor Intelligence / 2020年4月20日 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：健康管理 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ニュートリゲノミクスの世界市場について調査・分析した資料で、ニュートリゲノミクスの市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。 |
The Nutrigenomics Market is expected to register a CAGR of 15% during the forecast period. This is attributing to increasing awareness among the target population along with rise in the prevalence of obesity and the growing trend of personalized diet among athletes. As Nutrigenomics helps in understanding the genetic role in health and diseases with providing better therapeutic intervention that helps in diagnosing the diseases. With rising importance of nutrition among the population and several advantages such as a focus on disease prevention rather disease management and impeding the sign aging will result in propelling the nutrigenomics market. Furthermore, proper diet nutrition on an individual level may reduce the susceptibility of cancer thus results in boosting the overall market. However, the lack of regulatory approvals in the field of nutrigenomics may hamper the market.
Key Market Trends
Based on Application, Obesity in Nutrigenomics Market is Expected to witness a healthy growth in future
Obesity is expected to witness healthy growth in the future. As obesity is a major health concern worldwide which can lead to various diseases such as cardiovascular, type 2 diabetes, metabolic syndrome and sometimes cancer. Nutrigenomics helps in understanding the population on individual gene level and according to the genes, proper nutrition diet is given which further result in decreased obesity. This novel approach of nutrigenomics helps in the effective prevention and treatment of these diseases and is the key driving factor propelling the segment growth.
In Addition, With the increasing prevalence of obesity in women worldwide results in high demand of treatment and thus of propelling the nutrigenomics market.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a significant market share in the global Nutrigenomics Market due to the introduction and development of direct to consumer nutrigenomics kits and increasing intake of specialized food and diet in this region. Moreover, the rising prevalence of obesity population with the presence of an aging population, increasing healthcare expenditure and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.
Competitive Landscape
The Nutrigenomics Market is fragmented competitive and consists of several major players. Some of the companies which are currently dominating the market are DSM, BASF SE, Danone, Genova Diagnostics, Cell-Logic, Metagenics, Inc, and GeneSmart.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Obesity
4.2.2 Increasing Popularity for Personalised Diet
4.2.3 Intense Research for Cancer Prevention and Cure
4.3 Market Restraints
4.3.1 Lack of Regulatory Approvals
4.3.2 Lack of Proven Results for Nutrigenomics Study Support
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Application
5.1.1 Cardiovascular Diseases
5.1.2 Obesity
5.1.3 Cancer Research
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle-East and Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle-East and Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 DSM
6.1.2 BASF SE
6.1.3 Danone
6.1.4 Genova Diagnostics
6.1.5 Cell-Logic
6.1.6 Metagenics, Inc.
6.1.7 GeneSmart
7 MARKET OPPORTUNITIES AND FUTURE TRENDS